Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity
European Journal of Cancer2017Vol. 75, pp. 63–72
Citations Over TimeTop 10% of 2017 papers
Laurel T. Bate-Eya, Hinco J. Gierman, Marli E. Ebus, Jan Köster, Huib N. Caron, Rogier Versteeg, M. Emmy M. Dolman, Jan J. Molenaar
Related Papers
- → Purification and Functional Characterization of a Histone H3-Lysine 4-Specific Methyltransferase(2001)522 cited
- → Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2(2012)375 cited
- → A Subset of the Histone H3 Lysine 9 Methyltransferases Suv39h1, G9a, GLP, and SETDB1 Participate in a Multimeric Complex(2010)313 cited
- → Dynamic regulation of six histone H3 lysine (K) methyltransferases in response to prolonged anoxia exposure in a freshwater turtle(2018)41 cited
- → Abstract 2011: Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A against non-small cell lung cancer cells(2011)